Effect of levocarnitine administration in patients with chronic liver disease
Mark Schneider, Nestle CEO Future Outlook Companies are adopting diverse strategies, from launching new product lines to utilizing existing ingredients and repositioning current products to cater to the growing GLP-1 companion food market
Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
Peptides need refrigeration because they are fragile molecules that break down over time, and cold dramatically slows that breakdown.
For antioxidant support: 250 to 500mg daily
Regular water or saline nasal irrigation may also help keep respiratory infections at bay (AFP 2009)